Shobha Shukla, CNS Columnist
Both asthma and chronic obstructive pulmonary disease (COPD) are chronic diseases involving airflow obstruction and are consequences of gene environment interaction. COPD includes progressive respiratory diseases like emphysema and chronic bronchitis and is characterized by decreased airflow over time and increased inflammation. While airway obstruction in asthma is reversible, airflow limitation in COPD is usually not reversible, although one third of COPD patients do respond to bronchodilators agents and show good reversibility.
Both asthma and chronic obstructive pulmonary disease (COPD) are chronic diseases involving airflow obstruction and are consequences of gene environment interaction. COPD includes progressive respiratory diseases like emphysema and chronic bronchitis and is characterized by decreased airflow over time and increased inflammation. While airway obstruction in asthma is reversible, airflow limitation in COPD is usually not reversible, although one third of COPD patients do respond to bronchodilators agents and show good reversibility.